The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.70
Bid: 49.80
Ask: 49.95
Change: -0.80 (-1.58%)
Spread: 0.15 (0.301%)
Open: 50.00
High: 50.60
Low: 49.30
Prev. Close: 50.50
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Apr 2021 11:27

RNS Number : 6880U
IP Group PLC
07 April 2021
 

FOR RELEASE ON

7 April 2021

 

IP Group plc - Director/PDMR share dealing & SAYE option exercise

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), the developer of intellectual property-based businesses, announces that it has been notified of the following transactions in ordinary shares of 2 pence each in the Company ("Shares") by Directors and other Persons Discharging Managerial Responsibilities ("PDMRs") on Thursday 1 April 2021:

 

- Greg Smith, Chief Financial Officer, transferred, via sale and purchase, 17,000 Shares into his ISA. Mr Smith sold Shares at 125.5 pence per share and bought Shares at 125.7 pence per share. Following the transfer, Mr Smith's beneficial interest in the Company remains unchanged at 339,403 Shares, representing 0.03% of the total issued share capital.

- Angela Leach, General Counsel and Company Secretary, bought 15,020 Ordinary Shares into her ISA at 125.8 pence per share. Following the purchase, Ms Leach's beneficial interest in the Company is now 274,272 Shares, representing 0.03% of the total issued share capital.

- Dr Mark Reilly, Managing Partner Technology, exercised options under the Group's 2017 Save As You Earn plan ("SAYE") to buy 6,315 Shares at 114 pence per share. Following satisfaction of the options, Mr Reilly's beneficial interest in the Company will be 46,645 Shares, representing

 

Shares in issue

At the date of this announcement, the Company continues to have 1,062,353,734 ordinary shares in issue.

The following notifications, made in accordance with the requirements of article 19.3 of the EU Market Abuse Regulation, provide further details:

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Greg Smith

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

 ISIN: GB00B128J450

b)

Nature of the transaction

Sale and purchase of Shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

Sale

£1.255

17,000

Purchase

£1.257

17,000

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

 

Price(s)

Volume(s)

Aggregated total

Sale

£1.255

17,000

£21,336

Purchase

£1.257

17,000

£21,369

f)

Date of the transaction

Sale: 1 April 2021Purchase: 1 April 2021

g)

Place of the transaction

London

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Reilly

2

Reason for the notification

a)

Position/status

PDMR Managing Partner, Technology

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

 ISIN: GB00B128J450

b)

Nature of the transaction

Exercise of an option to acquire Ordinary Shares under the Group's 2017 SAYE.

c)

Currency

GBP

d)

Price(s) and volume(s)

Name(s)

Price(s)

Volume(s)

Mark Reilly

£1.14

6,315

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

 

6,315

Price: £1.14

£7,200

f)

Date of the transaction

1 April 2021

g)

Place of the transaction

London

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Angela Leach

2

Reason for the notification

a)

Position/status

PDMR - General Counsel & Company Secretary

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

 ISIN: GB00B128J450

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Name(s)

Price(s)

Volume(s)

Angela Leach

£1.2583

15,020

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

 

15,020

Price: £1.2583

£18,900

f)

Date of the transaction

1 April 2021

g)

Place of the transaction

London

 

 

 

 

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Greg Smith, Chief Financial OfficerAngela Leach, Company Secretary

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUAPCUPGGUM
Date   Source Headline
11th Dec 20187:00 amRNSWaveOptics completes £20.0m funding round
10th Dec 20187:05 amRNSAvacta signs deal with LG Chem worth up to $310m
4th Dec 20185:49 pmRNSPortfolio co Ceres finalises deal with Weichai
3rd Dec 20187:00 amRNSUltrahaptics completes £35.0m funding round
31st Oct 20185:52 pmRNSDirector Declaration
18th Oct 20182:00 pmRNSAmgen invests £50m in Oxford Nanopore Technologies
15th Oct 20187:00 amRNSPortfolio co Garrison completes £22.9m financing
8th Oct 20187:07 amRNSPortfolio co Diurnal headline data for Chronocort
19th Sep 20189:51 amRNSDirector/PDMR Shareholding
17th Sep 20184:58 pmRNSDirector/PDMR Shareholding
17th Sep 20184:38 pmRNSDirector/PDMR Shareholding
17th Sep 201812:12 pmRNSDirector/PDMR Shareholding
17th Sep 20187:00 amRNSAppointment of Chairman; Board changes
31st Aug 20189:55 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSGenomics announces Vertex leads £25m financing
29th Aug 20186:29 pmRNSIP Group plc -SAYE scheme
21st Aug 20187:06 amRNSCeres signs agreement with Bosch; £9m investment
10th Aug 20187:11 amRNSArtios Pharma completes £65m financing
31st Jul 20188:40 amRNSTR-1: NOTIFICATION
25th Jul 20187:00 amRNSHalf-yearly results
6th Jul 20187:00 amRNSNotification of Major Interest in Shares
4th Jul 20182:40 pmRNSCeres Power announces £20m fundraising
2nd Jul 20187:00 amRNSHolding(s) in Company
27th Jun 20187:30 amRNSCarisma announces $53m Series A funding round
27th Jun 20187:00 amRNSNotification of Major Interest in Shares
22nd Jun 201810:00 amRNSAppointment of Joint Broker
18th Jun 20181:37 pmRNSResult of AGM
7th Jun 20186:00 pmRNSHolding(s) in Company
6th Jun 20189:26 amRNSMicrobiotica signs collaboration worth up to $534m
16th May 201810:49 amRNSPortfolio co Ceres partners with Weichai Power
16th May 20187:00 amRNSNotice of AGM; Annual Report
11th May 20187:00 amRNSDirector/PDMR Shareholding
10th May 20186:18 pmRNSDirector/PDMR Shareholding
9th May 20185:31 pmRNSDirector share purchase
4th May 20187:00 amRNSBoard changes
30th Apr 20187:00 amRNSTotal Voting Rights
16th Apr 20185:45 pmRNSDirector/PDMR Shareholding
12th Apr 20189:19 amRNSEnterprise Therapeutics raises £29m
5th Apr 20181:12 pmRNSIP Group plc - Issue of Equity
4th Apr 201811:46 amRNSIP Group plc - Director/PDMR share purchase
29th Mar 20187:00 amRNSFinal Results
20th Mar 20187:00 amRNSOxford Nanopore announces £100m fundraising
17th Jan 201811:53 amRNSHolding(s) in Company
10th Jan 20189:12 amRNSHolding(s) in Company
2nd Jan 20187:00 amRNSTotal Voting Rights
18th Dec 201710:15 amRNSAutifony signs Eur627.5m agreement with BI
15th Dec 201712:50 pmRNSDiurnal receives positive CHMP opinion for Alkindi
14th Dec 20174:48 pmRNSDirectorate Change
13th Dec 20172:27 pmRNSIssue of Equity
8th Dec 20177:05 amRNSMirriad raises £26.2m; proposed admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.